sunitinib,cabozantinib,nivolumab
pfizer,exelixis,bms
['9er', 'improve']
in checkmate 9er, more pts receiving n+c achieved deeper responses vs sun. deeper responses were generally associated with improved pfs and os #asco22 
Medical oncologist. Clinical researcher focused in GU tumors. Director Institute of Oncology. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain